Detection of Epstein‐Barr Virus DNA in Reed‐Sternberg Cells of Hodgkin's Disease Using the Polymerase Chain Reaction and in situ Hybridization

Abstract

Thirty‐one cases of Hodgkin's disease were examined for the occurrence of Epstein‐Barr virus (EBV) genome by using the polymerase chain reaction (PCR) of DNA in formalin‐fixed paraffin‐embedded tissues and the in situ hybridization technique. The cases were subdivided into 17 cases of nodular sclerosis (NS), nine cases of mixed cellularity (MC), four cases of lymphocyte predominance (LP), and one case of lymphocyte depletion (LD). EBV DNA was detected in eight cases including four cases of NS, three cases of MC and one case of LP. The sensitivity of PCR was higher than that of Southern blot hybridization of DNA from fresh frozen tissue, because Southern blot hybridization using the BamHI‐W fragment of EBV detected virus DNA only in two of three cases which were positive by PCR. The results of in situ hybridization studies confirmed that EBV genome was localized within the nuclei of Reed‐Sternberg (RS) cells and their mononuclear variants. Furthermore, double‐labeling studies combining in situ hybridization and immunocytochemistry using CD30 (BerH2) and CD15 (LeuM1) as markers of RS cells, as well as pan B‐marker (L26) and pan T‐marker, CD45RO (UCHL1), were performed to demonstrate the phenotype of EBV DNA‐positive cells, confirming that EBV DNA was present in RS cells but not in lymphocytes. The results of this study indicate a significant association between EBV and some cases of Hodgkin's disease.

Plasmacytoma of the Gastrointestinal Tract in Korea: Higher Incidence than in Japan and Epstein-Barr Virus Association

“…For the amplification of ß-globin gene, 35 PCR cycles of 94-60-72°C were performed with primers designed to amplify a 123-bp segment in the exon 7-8 region. For the amplification of the EBV genome, 35 PCR cycles of 94-58-72°C were performed with primers designed to amplify a 129-bp segment in the BamHI-W region [13].…”

A Rapid and Reliable Enzyme Immunoassay PCR-Based Screening Method to Identify EBV-Carrying Gastric Carcinomas

“…Previous studies have evaluated the use of PCR and ISH for other EBV-associated malignancies including NPC (32)(33)(34), hypopharyngeal carcinomas (35), Hodgkin lymphomas (36,37), and non-Hodgkin lymphomas of the gastrointestinal tract (38) for research purposes. However, these studies used different methodical approaches to determine the presence of EBV.…”

Epstein-Barr virus in lymphoproliferative diseases in the sino-nasal region: Close association with CD56+ immunophenotype and polymorphic-reticulosis morphology

“…For the amplification of b-globin gene, 35 PCR cycles at 94°C-60°C-72°C was performed with primers designed to amplify the 123-bp segment in the exon 7-8 region (exon 7, 58-CTTCTGA-CACAACTGTGTTCACTAGC-38, and exon 8, 58-TCACCACCA-ACTTCATCCACGTTCAC-38) (Heller et al, 1992). For amplification of the EBV genome, 35 PCR cycles of 94°C-58°C-72°C were performed with primers designed to amplify the 129-bp segment in the BamHI-W region of the EBV genome (58-CCAGACAGCA-GCCAATTGTC-38, and 58-GGTAGAAGACCCCCTCTTAC-38) (Uhara et al, 1990).…”